as on November 13, 2025 at 2:29 am IST
Day's Low
Day's High
71.57%
Downside
24.51%
Upside
52 Week's Low
52 Week's High
89.10%
Downside
75.49%
Upside
Check Leap Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$-
EPS (TTM)
0Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
0.00%
Compare market cap, revenue, PE, and other key metrics of Leap Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $- | NA | NA | 0.00% | |
| BUY | $44.1B | 436.37% | -16.34 | -264.83% | |
| BUY | $57.7B | 246.14% | 1407.68 | 1.36% | |
| BUY | $109.4B | 94.41% | 30.03 | 31.35% | |
| BUY | $80.1B | 49.8% | 18.11 | 32.13% |
Based on 10 analysts
90.00%
Buy
10.00%
Hold
0.00%
Sell
Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Leap Therapeutics Inc. Average target price of $3
Get share price movements and forecasts by analysts on Leap Therapeutics Inc.
What analysts predicted
32%UPSIDE
Target Price
$3
Current Price
$2.04
Analyzed by
10 Analysts
Target
$3.00
Leap Therapeutics Inc target price $3, a slight upside of 32% compared to current price of $2.04. According to 10 analysts rating.
Investment in Leap Therapeutics Inc Shares on INDmoney has grown by 94.44% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:94.44% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 13 November
Thu, 02:16 PM
-Leap Therapeutics announces significant corporate changes, including rebranding to Cypherpunk Technologies and a digital asset treasury strategy.
Thu, 08:32 PM
-Leap Therapeutics stock surged 368% after announcing digital asset investments and rebranding, but fell 25% in pre-market trading.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, LPTX stock has moved up by 347.3%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 924.7% return, outperforming this stock by 995.6%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 172.8% return, outperforming this stock by 201.9%
| Organisation | Leap Therapeutics Inc |
| E-voting on shares | Click here to vote |
Leap Therapeutics Inc share price today is $2.04 as on . Leap Therapeutics Inc share today touched a day high of $2.54 and a low of $0.58.
Leap Therapeutics Inc share touched a 52 week high of $3.58 on and a 52 week low of $0.22 on . Leap Therapeutics Inc stock price today i.e. is trending at $2.04,which is 43.02% down from its 52 week high and 817.68% up from its 52 week low.
Indian investors can start investing in Leap Therapeutics Inc (LPTX) shares with as little as ₹89.162 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹891.62 in Leap Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Leap Therapeutics Inc share’s latest price of $2.04 as on November 13, 2025 at 2:29 am IST, you will get 4.9020 shares of Leap Therapeutics Inc. Learn more about
fractional shares .